CH540244A - Verfahren zur Herstellung neuer Halogenpregnadiene - Google Patents

Verfahren zur Herstellung neuer Halogenpregnadiene

Info

Publication number
CH540244A
CH540244A CH1746670A CH1746670A CH540244A CH 540244 A CH540244 A CH 540244A CH 1746670 A CH1746670 A CH 1746670A CH 1746670 A CH1746670 A CH 1746670A CH 540244 A CH540244 A CH 540244A
Authority
CH
Switzerland
Prior art keywords
acid
formula
chloro
hydrogen fluoride
hydroxyl group
Prior art date
Application number
CH1746670A
Other languages
German (de)
English (en)
Inventor
Georg Dr Anner
Ludwig Dr Ehmann
Jaroslav Dr Kalvoda
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to CH1746670A priority Critical patent/CH540244A/de
Publication of CH540244A publication Critical patent/CH540244A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01RELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R33/00Coupling devices specially adapted for supporting apparatus and having one part acting as a holder providing support and electrical connection via a counterpart which is structurally associated with the apparatus, e.g. lamp holders; Separate parts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
CH1746670A 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene CH540244A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH1746670A CH540244A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1610167A CH510655A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene
CH1746670A CH540244A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene

Publications (1)

Publication Number Publication Date
CH540244A true CH540244A (de) 1973-08-15

Family

ID=4414467

Family Applications (4)

Application Number Title Priority Date Filing Date
CH1746670A CH540244A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene
CH1610167A CH510655A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene
CH1746770A CH513845A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene
CH251171A CH534144A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene

Family Applications After (3)

Application Number Title Priority Date Filing Date
CH1610167A CH510655A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene
CH1746770A CH513845A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene
CH251171A CH534144A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene

Country Status (15)

Country Link
US (1) US3652554A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS4829221B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (3) AT298695B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE723905A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR6804024D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (4) CH540244A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK129835B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR1594773A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1245292A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY7400317A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL161767C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL80570B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE351634B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU424352A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (4) YU34138B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010458B2 (de) * 1970-02-28 1979-04-26 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 21-Halogensteroide
CH558787A (de) * 1970-12-10 1975-02-14 Ciba Geigy Ag Verfahren zur herstellung eines neuen halogenpregnadiens.
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
NL7502252A (nl) * 1974-02-27 1975-08-29 Pierrel Spa Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden.
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
FR2291760A1 (fr) * 1974-11-19 1976-06-18 Pierrel Spa Nouveaux steroides a base de 2-chloro-6 b-fluoro-pregna-1,4-diene-3,20-diones
GB1505701A (en) * 1975-06-14 1978-03-30 Pierrel Spa 2-chloro-6beta-fluoropregnanes
DE2655570A1 (de) * 1975-12-12 1977-06-16 Ciba Geigy Ag Neue polyhalogensteroide und verfahren zu ihrer herstellung
US7825147B2 (en) * 2003-08-29 2010-11-02 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
AU2007298549A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
PT2124944E (pt) * 2007-03-14 2012-05-17 Ranbaxy Lab Ltd Derivados de pirazolo[3,4-b]piridina como inibidores de fosfodiesterase
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN102827229B (zh) * 2011-06-17 2016-01-20 重庆华邦胜凯制药有限公司 一种纯化卤米松羧酸酯的方法
CN104370987B (zh) * 2014-10-22 2016-09-14 湖南明瑞制药有限公司 一种卤米松的精制方法
CN111944004B (zh) * 2020-09-25 2023-11-17 湖南新合新生物医药有限公司 一种卤米松的制备方法

Also Published As

Publication number Publication date
AT298695B (de) 1972-05-25
YU34138B (en) 1978-12-31
MY7400317A (en) 1974-12-31
US3652554A (en) 1972-03-28
AT293633B (de) 1971-10-25
SE351634B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-12-04
BR6804024D0 (pt) 1973-01-02
YU30775A (en) 1982-05-31
CH510655A (de) 1971-07-31
NL6816337A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1969-05-20
CH534144A (de) 1973-02-28
DK129835C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-05-05
NL161767C (nl) 1980-03-17
JPS4829221B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-09-08
AT298690B (de) 1972-04-15
YU30675A (en) 1982-05-31
FR1594773A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1970-06-08
PL80570B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-08-30
FR8278M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1970-11-02
CH513845A (de) 1971-10-15
YU267368A (en) 1978-06-30
DE1807980B2 (de) 1975-11-06
SU424352A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-04-15
DK129835B (da) 1974-11-25
DE1807980A1 (de) 1969-06-04
YU30875A (en) 1982-05-31
GB1245292A (en) 1971-09-08
BE723905A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1969-05-14

Similar Documents

Publication Publication Date Title
CH540244A (de) Verfahren zur Herstellung neuer Halogenpregnadiene
DE2707336C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0072547B1 (de) Neue 6-alpha-Methylprednisolon-Derivate ihre Herstellung und Verwendung
EP0110041B1 (de) Neue 6alpha-Methylkortikoide, ihre Herstellung und Verwendung
CH499506A (de) Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate
EP0005758B1 (de) Verfahren zum Aufbau der Hydroxyacetyl-Seitenkette von Steroiden des Pregnan-Typs, neue 21-Hydroxy-20-oxo-17alpha-pregnan-Verbindungen und pharmazeutische Präparate enthaltend dieselben
DE2632678C2 (de) 6α-Fluor-12α-Halogen-Kortikoide und Verfahren zu ihrer Herstellung
CH637407A5 (de) Verfahren zur herstellung neuer kortikoide.
DE2365992A1 (de) 6 alpha-fluor-17,21-dihydroxy-16 beta-methylpregna-4,9(11)-dien-3,20- dion-17,21-diacetat und verfahren zu dessen herstellung
DE2448662C2 (de) 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AT292210B (de) Verfahren zur Herstellung von neuen in 2-Stellung durch Chlor substituierten Steroiden der Pregnanreihe
DE1493178C3 (de) 6 alpha-Fluor-16 alpha-methyl-1,4pregnadien-3,20-dion-derivate und Verfahren zu ihrer Herstellung
DE2150268A1 (de) Neue pregnansaeure-derivate
CH625254A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE1930982C3 (de) 6alpha-Fluor-2,9alpha,11 betatrichlor-16alpha-methyl-verbindungen der Pregnanreihe
AT364098B (de) Verfahren zur herstellung von neuen estern von androstadien-17-carbonsaeuren
CH547790A (de) Verfahren zur herstellung neuer halogenpregnadiene.
DE1802962C3 (de) Neue Galpha, 6beta-Dlfluorsteroide, Verfahren zu ihrer Herstellung, sowie diese enthaltende Mittel
DE1807980C3 (de) Verfahren zur Herstellung neuer Halogenpregnadiene
EP0011121A1 (de) Hydrocortisonester, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
CH551399A (de) Verfahren zur herstellung neuer halogenpregnadiene.
DE1593519B2 (de) Verfahren zur Herstellung von 11 beta-Hydroxy-^alpha-niederalkanoyloxyestern der Pregnanreihe
DE1468892C (de) Verfahren zur Herstellung von Steroid-21-apocarnphan-l' -carboxylaten mit lokaler antiinflammatorischer Wirkung
AT368522B (de) Verfahren zur herstellung von neuen 2,9alpha-
AT232662B (de) Verfahren zur Herstellung von in 1- und 4-Stellung ungesättigten Steroiden

Legal Events

Date Code Title Description
PL Patent ceased